← Back to all earnings calls

Avalo Therapeutics, Inc. Q3 FY2020 Earnings Call

Avalo Therapeutics, Inc. (AVTX)

Earnings Call FY2020 Q3 Call date: 2020-11-09 Concluded

Share

Quarter scorecard

Revenue

$1.11M

-49.5% YoY

Net income

$

Revenue · products & services

Product $1.11M

-47.1%

License $

-100%

Documents & deck